Gapping down
In reaction to disappointing earnings/guidance:
- N/A.
M&A news:
- TSLA -3.1% (Tesla says it will remain a public company)
Other news:
- ESPR -1.2% (despite announcing'positive' top-line results from the pivotal Phase 3 bempedoic acid / ezetimibe combination pill )
Analyst comments:
- BE -4.4% (downgraded to Underperform from Neutral at Credit Suisse)
- X -1.9% (downgraded to Underweight from Overweight at Morgan Stanley)
- CMG -1.6% (downgraded to Underperform from Neutral at Wedbush)
- AEO -1.4% (downgraded to Neutral from Outperform at Wedbush)
![]()